Literature DB >> 6941852

Induction of differentiation of cultured human and mouse myeloid leukemia cells by alkyl-lysophospholipids.

Y Honma, T Kasukabe, M Hozumi, S Tsushima, H Nomura.   

Abstract

Alkyl-lysophospholipids are synthetic analogs of naturally occurring lysophospholipids. The effects of these compounds on cell proliferation and differentiation of cultured human (HL-60) and mouse (M1) myeloid leukemia cells were studied. Both cell lines were induced to differentiate into morphologically and functionally mature granulocytes and macrophages by incubation with a wide variety of these compounds. Some alkyl-lysophospholipids induced differentiation (judged morphologically and by the appearance of abilities to reduce nitro blue tetrazolium, to phagocytize latex particles, and to induce lysozyme activity) of both the cells lines at concentrations of 1 microgram/ml. However, these compounds did not affect colony formation of normal mouse bone marrow cells even at a higher concentration, 20 microgram/ml. These results suggest that alkyl-lysophospholipids induce cell differentiation of myeloid leukemia cells without affecting proliferation and differentiation of normal bone marrow cells. Thus, these compounds could be useful in therapy of myeloid leukemia.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941852

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Guinea pig bone marrow cells treated with platelet-activating factor generate factor(s) which affects their DNA synthesis and microbicidal activity.

Authors:  I Kudo; T Kato; H Hayashi; R Yanoshita; K Ikizawa; H Uda; K Inoue
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  Synthesis and biological evaluation of ether-linked derivatives of phosphatidylinositol.

Authors:  K S Ishaq; M Capobianco; C Piantadosi; A Noseda; L W Daniel; E J Modest
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

3.  A novel bioaction of PAF: induction of microbicidal activity in guinea pig bone marrow cells.

Authors:  H Hayashi; I Kudo; T Kato; R Nozawa; S Nojima; K Inoue
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

Review 4.  Emerging drug treatments for solid tumours.

Authors:  J H Schellens; L C Pronk; J Verweij
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

Review 5.  Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience.

Authors:  W E Berdel
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

6.  Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells.

Authors:  C Hochhuth; D Berkovic; H Eibl; C Unger; D Doenecke
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

Review 7.  Signal transduction pathways: new targets in oncology.

Authors:  R K Sweeb; J H Beijnen
Journal:  Pharm World Sci       Date:  1993-12-17

8.  Antileukemic effect of alkyl phospholipids. I. Inhibition of proliferation and induction of differentiation of cultured myeloid leukemia cells by alkyl ethyleneglycophospholipids.

Authors:  Y Honma; T Kasukabe; J Okabe-Kado; M Hozumi; S Tsushima; H Nomura
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Effect of ether lipids on mouse granulocyte-macrophage progenitor cells.

Authors:  K Vehmeyer; D J Kim; G A Nagel; H Eibl; C Unger
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

10.  Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.

Authors:  I Dulisch; H A Neumann; G W Löhr; R Andreesen
Journal:  Blut       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.